A new dawn in the sleep disorders pipeline?
Waldemar
W
Ockert
D015195:Drug Design; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology / Q000627:therapeutic use*; D058990:Molecular Targeted Therapy; D012894:Sleep Stages; D012893:Sleep Wake Disorders / Q000188:drug therapy* / Q000503:physiopathology; D012895:Sleep, REM
D006993:Hypnotics and Sedatives